During the past decade, New England Regional Headache Center Inc conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 10 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New England Regional Headache Center Inc" #1 sponsor was "Allergan" with 4 trials, followed by "Amgen" with 4 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Alexza Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New England Regional Headache Center Inc" #1 collaborator was "Novartis" with 3 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New England Regional Headache Center Inc" are "Migraine" (7 trials), "Migraine Disorders" (3 trials), "Migraine, With or Without Aura" (3 trials), "Cluster Headache" (2 trials) and "Aura" (1 trials). Many other conditions were trialed in "New England Regional Headache Center Inc" in a lesser frequency.

Most popular intervention types in "New England Regional Headache Center Inc" are "Drug" (14 trials), "Device" (4 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Erenumab Dose 1" (2 trials), "Erenumab Dose 2" (2 trials), "Erenumab Dose 3" (2 trials) and "Lasmiditan" (2 trials). Other intervention names were less common.

The vast majority of trials in "New England Regional Headache Center Inc" are 17 trials for "All" genders.

Currently, there are NaN active trials in "New England Regional Headache Center Inc". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in New England Regional Headache Center Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in New England Regional Headache Center Inc, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".